Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
CALL
Tenaya Therapeutics
TNYA
$163M
| $61.4K | ﹤0.01% |
19,800
-1,400
| -7% | -$5.78K |
|
11452
SkinHealth Systems
SKIN
$86.8M
| $61.4K | ﹤0.01% |
31,966
-1,214,734
| -97% | -$3.42M |
|
|
TRUE
11453
CALL
DELISTED
TrueCar
TRUE
| $61.3K | ﹤0.01% |
19,600
-15,000
| -43% | -$43.9K |
|
|
GRTS
11454
PUT
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $61.2K | ﹤0.01% |
99,100
-164,200
| -62% | -$139K |
|
11455
CALL
Wabash National
WNC
$512M
| $61.2K | ﹤0.01% |
2,800
-4,900
| -64% | -$115K |
|
11456
CALL
Prosperity Bancshares
PB
$9.02B
| $61.1K | ﹤0.01% |
1,000
-2,200
| -69% | -$136K |
|
11457
CALL
Spyre Therapeutics
SYRE
$9.14B
| $61.1K | ﹤0.01% |
+2,600
| New | +$87.7K |
|
11458
Kadant
KAI
$3.95B
| $61.1K | ﹤0.01% |
208
-905
| -81% | -$258K |
|
|
PBPB
11459
CALL
DELISTED
Potbelly
PBPB
| $61K | ﹤0.01% |
7,600
-7,200
| -49% | -$66.7K |
|
|
DMRA
11460
Damora Therapeutics
DMRA
$1.92B
| $61K | ﹤0.01% |
5,143
+1,403
| +38% | +$22.2K |
|
|
ETHU
11461
PUT
2x Ether ETF
ETHU
$712M
| $60.9K | ﹤0.01% |
+260
| New | +$68.8K |
|
11462
ESS Tech
GWH
$20.4M
| $60.9K | ﹤0.01% |
+4,964
| New | +$55.9K |
|
11463
CALL
SoundThinking
SSTI
$81.6M
| $60.9K | ﹤0.01% |
5,000
+300
| +6% | +$4.26K |
|
11464
PUT
NovaGold Resources
NG
$3.48B
| $60.9K | ﹤0.01% |
17,600
-5,900
| -25% | -$19.6K |
|
11465
CALL
Hackett Group
HCKT
$265M
| $60.8K | ﹤0.01% |
2,800
-10,200
| -78% | -$226K |
|
11466
Inuvo
INUV
$12.9M
| $60.7K | ﹤0.01% |
23,656
-15,307
| -39% | -$46.6K |
|
|
RDNW
11467
PUT
RideNow Group
RDNW
$248M
| $60.7K | ﹤0.01% |
14,800
+8,400
| +131% | +$46K |
|
11468
PUT
Rekor Systems
REKR
$98.2M
| $60.6K | ﹤0.01% |
39,100
-11,700
| -23% | -$20.5K |
|
|
VERV
11469
CALL
DELISTED
Verve Therapeutics
VERV
| $60.5K | ﹤0.01% |
12,400
-25,400
| -67% | -$160K |
|
|
VIVS
11470
VivoSim Labs
VIVS
$1.13M
| $60.4K | ﹤0.01% |
6,605
+2,740
| +71% | +$32.3K |
|
11471
PUT
Puma Biotechnology
PBYI
$456M
| $60.3K | ﹤0.01% |
18,500
| – | – |
|
11472
NBT Bancorp
NBTB
$2.78B
| $60.2K | ﹤0.01% |
+1,559
| New | +$56.4K |
|
11473
PUT
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $60.2K | ﹤0.01% |
400
-900
| -69% | -$137K |
|
|
MRX
11474
PUT
Marex Group Limited Ordinary Shares
MRX
$5.11B
| $60K | ﹤0.01% |
+3,000
| New | +$59K |
|
11475
PUT
ZipRecruiter
ZIP
$386M
| $60K | ﹤0.01% |
6,600
-4,000
| -38% | -$40.4K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.